Stem-cell ecology and stem cells in motion

Blood

Volumn 111, Issue 8, 2008, Pages 3923-3930

  Papayannopoulou, Thalia ^a   Scadden, David T ^b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN RECEPTOR; BETA2 INTEGRIN; CATHEPSIN; CD135 ANTIGEN; CHEMOKINE RECEPTOR CXCR4; ELASTASE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; FIBRONECTIN; HERMES ANTIGEN; INTERLEUKIN 8; MATRIX METALLOPROTEINASE; OSTEOPONTIN; PROTEIN P21; PROTEINASE; RAC1 PROTEIN; RAC2 PROTEIN; RETINOIC ACID RECEPTOR GAMMA; STROMAL CELL DERIVED FACTOR 1; TRANSFORMING GROWTH FACTOR BETA; VASCULAR CELL ADHESION MOLECULE 1; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1; VERY LATE ACTIVATION ANTIGEN 4;

BONE MARROW; CELL INTERACTION; CELL MIGRATION; HEMATOPOIESIS; HEMATOPOIETIC CELL; HUMAN; LEUKEMIA CELL; MESENCHYMAL STEM CELL; PRIORITY JOURNAL; REVIEW; STEM CELL; STEM CELL MOBILIZATION; ANIMAL; BONE; CELL MOTION; CYTOLOGY; LEUKEMIA; PATHOLOGY;

ANIMALS; BONE AND BONES; CELL MOVEMENT; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL MOBILIZATION; HUMANS; LEUKEMIA; STEM CELLS;

EID: 43249101948     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2007-08-078147     Document Type: Review

References (103)

1. Till JE, McCulloch EA. A direct measurement of the radiation sensitivity of normal mouse bone marrow cells. Radiat Res. 1961;14:213-222.
2. Schofield R. The relationship between the spleen colony-forming cell and the haemopoietic stem cell. Blood Cells. 1978;4:7-25.
3. Dexter TM, Allen TD, Lajtha LG. Conditions controlling the proliferation of haemopoietic stem cells in vitro. J Cell Physiol. 1977;91:335-344.
4. Lord BI, Testa NG, Hendry JH. The relative spatial distributions of CFUs and CFUc in the normal mouse femur. Blood. 1975;46:65-72.
5. Xie T, Spradling AC. Decapentaplegic is essential for the maintenance and division of germline stem cells in the drosophila ovary. Cell. 1998;94:251-260.
6. Kiger AA, White-Cooper H, Fuller MT. Somatic support cells restrict germline stem cell self-renewal and promote differentiation. Nature. 2000;407:750-754.
7. Crittenden SL, Bernstein DS, Bachorik JL, et al. A conserved RNA-binding protein controls germline stem cells in Caenorhabditis elegans. Nature. 2002;417:660-663.
8. Maloney MA, Patt HM. Origin in repopulating cells after localized bone marrow depletion. Science. 1968;165:71-73.
9. Lord BI, Hendry JH. The distribution of haemopoietic colony-forming units in the mouse femur, and its modification by x rays. Br J Radiol. 1972;45:110-115.
10. Taichman RS, Reilly MJ, Emerson SG. Human osteoblasts support human hematopoietic progenitor cells in vitro bone marrow cultures. Blood. 1996;87:518-524.
11. Zhang J, Niu C, Ye L, et al. Identification of the haematopoietic stem cell niche and control of the niche size. Nature. 2003;425:836-841.
12. Calvi LM, Adams GB, Weibrecht KW, et al. Osteoblastic cells regulate the haematopoietic stem cell niche. Nature. 2003;425:841-846.
13. Arai F, Hirao A, Ohmura M, et al. Tie2/angiopoietin-1 signaling regulates hematopoietic stem cell quiescence in the bone marrow niche. Cell. 2004;118:149-161.
14. Visnjic D, Kalajzic Z, Rowe DW, Katavic V, Lorenzo J, Aguila HL. Hematopoiesis is severely
15. altered in mice with an induced osteoblast deficiency. Blood. 2004;103:3258-3264.
16. Nilsson SK, Johnston HM, Whitty GA, et al. Os teopontin, a key component of the hematopoietic stem cell niche and regulator of primitive hematopoietic progenitor cells. Blood. 2005;106:1232-1239.
17. Stier S, Ko Y, Forkert R, et al. Osteopontin is a hematopoietic stem cell niche component that negatively regulates stem cell pool size. J Exp Med. 2005;201:1781-1791.
18. Adams GB, Chabner KT, Alley IR, et al. Stem cell engraftment at the endosteal niche is specified by the calcium-sensing receptor. Nature. 2006;439:599-603.
19. Kiel MJ, Yilmaz OH, Iwashita T, Yilmaz OH, Terhorst C, Morrison SJ. SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells. Cell. 2005;121:1109-1121.
20. Sipkins DA, Wei X, Wu JW, et al. In vivo imaging of specialized bone marrow endothelial microdomains for tumour engraftment. Nature. 2005;435:969-973.
21. Sugiyama T, Kohara H, Noda M, Nagasawa T. Maintenance of the hematopoietic stem cell pool by CXCL12-CXCR4 chemokine signaling in bone marrow stromal cell niches. Immunity. 2006;25:977-988.
22. Wilson A, Trumpp A. Bone-marrow haematopoietic-stem-cell niches. Nat Rev Immunol. 2006;6:93-106.
23. Maximow AA. Relation of blood cells to connective tissues and endothelium. Physiol Rev. 1924;IV:533-563.
24. Goodman JW, Hodgson GS. Evidence for stem cells in the peripheral blood of mice. Blood. 1962;19:702-714.
25. Cronkite EP. Response to "mobilization of peripheral blood 'stem' cells: where there is smoke, is there fire?" yes, there have been many fires, leaving cold coals. Exp Hematol. 1997;25:185-186.
26. Vos O, Buurman WA, Ploemacher RE. Mobilization of haemopoietic stem cells (CFU) into the peripheral blood of the mouse; effects of endotoxin and other compounds. Cell Tissue Kinet. 1972;5:467-479.
27. Cline MJ, Golde DW. Mobilization of hematopoietic stem cells (CFU-C) into the peripheral blood of man by endotoxin. Exp Hematol. 1977;5:186-190.
28. Feher I, Gidali J. Self-renewal capacity of mobilized murine haemopoietic stem cells. Haematologia (Budap). 1987;20:15-23.
29. Monette FC, Morse BS, Howard D, Niskanen E, Stohlman F Jr. Hemopoietic stem cell proliferation and migration following Bordetella pertussis vaccine. Cell Tissue Kinet. 1972;5:121-129.
30. Quesenberry P, Levin K, Zuckerman K, Rencricca N, Sullivan R, Tyler W. Stem cell migration induced by erythropoietin or haemolytic anaemia: the effects of actinomycin and endotoxin contamination of erythropoietin preparations. Br J Haematol. 1979;41:253-269.
31. Mangalik A, Robinson WA. Mechanism of poly I: poly C stimulation of human bone marrow colony growth in vitro. Proc Soc Exp Biol Med. 1978;158:151-155.
32. Wilschut IJ, Erkens-Versluis ME, Ploemacher RE, Benner R, Vos O. Studies on the mechanism of haemopoietic stem cell (CFUs) mobilization: a role of the complement system. Cell Tissue Kinet. 1979;12:299-311.
33. Ruscetti FW, Chervenick PA. Release of colony-stimulating factor from monocytes byendotoxin and polyinosinic-polycytidylic acid. J Lab Clin Med. 1974;83:64-72.
34. Shirota T, Tavassoli M. Cyclophosphamide-induced alterations of bone marrow endothelium: implications in homing of marrow cells after transplantation. Exp Hematol. 1991;19:369-373.
35. Nothdurft W, Steinbach KH, Ross WM, Fliedner TM. Quantitative aspects of granulocytic progenitor cell (CFUc) mobilization from extravascular sites in dogs using dextran sulphate (DS). Cell Tissue Kinet. 1982;15:331-340.
36. Ross WM, Koerbling M, Nothdurft W, Fliedner TM. The role of dextran sulfate in increasing the CFUc-concentration in dog blood. Proc Soc Exp Biol Med. 1978;157:301-305.
37. Richman CM, Weiner RS, Yankee RA. Increase in circulating stem cells following chemotherapy in man. Blood. 1976;47:1031-1039.
38. Abrams RA, McCormack K, Bowles C, Deis-seroth AB. Cyclophosphamide treatment expands the circulating hematopoietic stem cell pool in dogs. J Clin Invest. 1981;67:1392-1399.
39. Fliedner TM. The role of blood stem cells in hematopoietic cell renewal. Stem Cells. 1998;16:361-374.
40. Dorie MJ, Maloney MA, Patt HM. Turnover of circulating hematopoietic stem cells. Exp Hematol. 1979;7:483-489.
41. Gerhartz HH, Fliedner TM. Velocity sedimentation
42. and cell cycle characteristics of granulopoietic progenitor cells (CFUc) in canine blood and bone marrow: influence of mobilization and CFUc depletion. Exp Hematol. 1980;8:209-218.
43. Papayannopoulou T. Current mechanistic scenarios in hematopoietic stem/progenitor cell mobilization. Blood. 2004;103:1580-1585.
44. Nervi B, Link DC, DiPersio JF. Cytokines and hematopoietic stem cell mobilization. J Cell Biochem. 2006;99:690-705.
45. Mohle R, Kanz L. Hematopoietic growth factors for hematopoietic stem cell mobilization and expansion. Semin Hematol. 2007;44:193-202.
46. Papayannopoulou T, Nakamoto B, Andrews RG, Lyman SD, Lee MY. In vivo effects of Flt3/Flk2 ligand on mobilization of hematopoietic progenitors in primates and potent synergistic enhancement with granulocyte colony-stimulating factor. Blood. 1997;90:620-629.
47. Lord BI, Woolford LB, Wood LM, et al. Mobilization of early hematopoietic progenitor cells with BB-10010: a genetically engineered variant of human macrophage inflammatory protein-1 alpha. Blood. 1995;85:3412-3415.
48. Liles WC, Broxmeyer HE, Rodger E, et al. Mobilization of hematopoietic progenitor cells in healthy volunteers by AMD3100, a CXCR4 antagonist. Blood. 2003;102:2728-2730.
49. Pelus LM, Bian H, King AG, Fukuda S. Neutrophil-derived MMP-9 mediates synergistic mobilization of hematopoietic stem and progenitor cells by the combination of G-CSF and the chemokines GRO{beta}/CXCL2 and GRO{beta}T/ CXCL2{Delta}4. Blood. 2004;103:110-119.
50. Korbling M, Przepiorka D, Huh YO, et al. Allogeneic blood stem cell transplantation for refractory leukemia and lymphoma: potential advantage of blood over marrow allografts [see comments]. Blood. 1995;85:1659-1665.
51. Reiffers J, Bernard P, David B, et al. Successful autologous transplantation with peripheral blood hemopoietic cells in a patient with acute leukemia. Exp Hematol. 1986;14:312-315.
52. Wright DE, Wagers AJ, Gulati AP, Johnson FL Weissman IL. Physiological migration of hematopoietic stem and progenitor cells. Science. 2001;294:1933-1936.
53. Abkowitz JL, Robinson AE, Kale S, Long MW, Chen J. Mobilization of hematopoietic stem cells during homeostasis and after cytokine exposure. Blood. 2003;102:1249-1253.
54. Lapidot T, Petit I. Current understanding of stem cell mobilization: the roles of chemokines, proteolytic enzymes, adhesion molecules, cytokines, and stromal cells. Exp Hematol. 2002;30:973-981.
55. Pelus LM, Horowitz D, Cooper SC, King AG. Peripheral blood stem cell mobilization: A role for CXC chemokines. Crit Rev Oncol/Hematol. 2002;43:257-275.
56. Kopp H-G, Avecilla ST, Hooper AT, Rafii S. The bone marrow vascular niche: home of HSC differentiation and mobilization. Physiology. 2005;20:349-356.
57. Papayannopoulou T, Nakamoto B. Peripheralization of hemopoietic progenitors in primates treated with anti-VLA4 integrin. Proc Natl Acad Sci U S A. 1993;90:9374-9378.
58. Luster AD, Alon R, von Andrian UH. Immune cell migration in inflammation: present and future therapeutic targets. Nat Immunol. 2005;6:1182-1190.
59. Scott L, Priestley G, Papayannopoulou T. Deletion of alpha4 integrins from adult hematopoietic cells reveals roles in homeostasis, regeneration, and homing. Mol Cell Biol. 2003;23:9349-9360.
60. Priestley GV, Ulyanova T, Papayannopoulou T. Sustained alterations in biodistribution of stem/ progenitor cells in Tie2Cre+{alpha}4f/f mice are hematopoietic cell autonomous. Blood. 2007;109:109-111.
61. Papayannopoulou, Priestley GV, Nakamoto B, Zafiropoulos V, Scott LM, Harlan JM. Synergistic mobilization of hemopoietic progenitor cells using concurrent β1 and β2 integrin blockade or β2-deficient mice. Blood. 2001;97:1282-1288.
62. Shen H, Cheng T, Olszak I, et al. CXCR-4 desensitization is associated with tissue localization of hemopoietic progenitor cells. J Immunol. 2001;166:5027-5033.
63. Papayannopoulou T, Priestley GV, Bonig H, Nakamoto B. The role of G-protein signaling in hematopoietic stem/progenitor cell mobilization. Blood. 2003;101:4739-4747.
64. Sweeney EA, Lortat-Jacob H, Priestley GV, Nakamoto B, Papayannopoulou T. Sulfated polysaccharides increase plasma levels of SDF-1 in monkeys and mice: involvement in mobilization of stem/progenitor cells. Blood. 2002;99:44-51.
65. Levesque J-P, Hendy J, Takamatsu Y, Simmons PJ, Bendall LJ. Disruption of the CXCR4/CXCL12 chemotactic interaction during hematopoietic stem cell mobilization induced by GCSF or cyclophosphamide. J Clin Invest. 2003;111:187-196.
66. -/- chimeric mice. Blood. 2006;107:2243-2251.
67. Kawabata K, Ujikawa M, Egawa T, et al. A cell-autonomous requirement for CXCR4 in long-term lymphoid and myeloid reconstitution. Proc Natl Acad Sci U S A. 1999;96:5663-5667.
68. Ma Q, Jones D, Springer TA. The chemokine receptor CXCR4 is required for the retention of B lineage and granulocytic precursors within the bone marrow microenvironment. Immunity. 1999;10:463-471.
69. Cancelas JA, Lee AW, Prabhakar R, Stringer KF, Zheng Y, Williams DA. Rac GTPases differentially integrate signals regulating hematopoietic stem cell localization. Nat Med. 2005;11:886-891.
70. Pelus LM, Bian H, Fukuda S, Wong D, Merzouk A, Salari H. The CXCR4 agonist peptide, CTCE-0021, rapidly mobilizes polymorphonuclear neutrophils and hematopoietic progenitor cells into peripheral blood and synergizes with granulocyte colony-stimulating factor. Exp Hematol. 2005;33:295-307.
71. Thomas J, Liu F, Link DC. Mechanisms of mobilization of hematopoietic progenitors with granulocyte colony-stimulating factor. Curr Opin Hematol. 2002;9:183-189.
72. Levesque J-P, Liu F, Simmons PJ, et al. Characterization of hematopoietic progenitor mobilization in protease-deficient mice. Blood. 2004;104:65-72.
73. Semerad CL, Christopher MJ, Liu F, et al. G-CSF potently inhibits osteoblast activity and CXCL12 mRNA expression in the bone marrow. Blood. 2005;106:3020-3027.
74. Katayama Y, Battista M, Kao W-M, et al. Signals from the sympathetic nervous system regulate hematopoietic stem cell egress from bone marrow. Cell. 2006;124:407-421.
75. Kollet O, Dar A, Lapidot T. The multiple roles of osteoclasts in host defense: bone remodeling and hematopoietic stem cell mobilization. Ann Rev Immunol. 2007;25:51-69.
76. Devine SM, Flomenberg N, Vesole DH, et al. Rapid mobilization of CD34+ cells following administration of the CXCR4 antagonist AMD3100 to patients with multiple myeloma and non-Hodgkin's lymphoma. J Clin Oncol. 2004;22:1095-1102.
77. Carlo-Stella C, Di Nicola M, Milani R, et al. Use of recombinant human growth hormone (rhGH) plus recombinant human granulocyte colony-stimulating factor (rhG-CSF) for the mobilization and collection of CD34+ cells in poor mobilizers. Blood. 2004;103:3287-3295.
78. Adams GB, Martin RP, Alley IR, et al. Therapeutic
79. targeting of a stem cell niche. Nat Biotech. 2007;25:238-243.
80. Purton LE, Dworkin S, Olsen GH, et al. RAR{gamma} is critical for maintaining a balance between hematopoietic stem cell self-renewal and differentiation. J Exp Med. 2006;203:1283-1293.
81. Walkley CR, Shea JM, Sims NA, Purton LE, Orkin SH. Rb regulates interactions between hematopoietic stem cells and their bone marrow microen-vironment. Cell. 2007;129:1081-1095.
82. Bonnet D, Dick JE. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med. 1997;3:730-737.
83. Wang JCY, Dick JE. Cancer stem cells: lessons from leukemia: trends in cell biology. 2005;15:494-501.
84. Bendall LJ, Kortlepel K, Gottlieb DJ. Human acute myeloid leukemia cells bind to bone marrow stroma via a combination of beta-1 and beta-2 integrin mechanisms. Blood. 1993;82:3125-3132.
85. Matsunaga T, Takemoto N, Sato T, et al. Interaction between leukemic-cell VLA-4 and stromal fibronectin is a decisive factor for minimal residual disease of acute myelogenous leukemia. Nat Med. 2003;9:1158-1165.
86. Tavor S, Petit I, Porozov S, et al. CXCR4 regulates migration and development of human acute myelogenous leukemia stem cells in transplanted NOD/SCID mice. Cancer Res. 2004;64:2817-2824.
87. Crazzolara R, Kreczy A, Mann G, et al. High expression of the chemokine receptor CXCR4 predicts extramedullary organ infiltration in childhood acute lymphoblastic leukaemia. Brit J Haematol. 2001;115:545-553.
88. Zeng Z, Samudio IJ, Munsell M, et al. Inhibition of CXCR4 with the novel RCP168 peptide overcomes stroma-mediated chemoresistance in chronic and acute leukemias. Mol Cancer Ther. 2006;5:3113-3121.
89. Jin L, Hope KJ, Zhai Q, Smadja-Joffe F, Dick JE. Targeting of CD44 eradicates human acute myeloid leukemic stem cells. Nat Med. 2006;12:1167-1174.
90. Krause DS, Lazarides K, von Andrian UH, Van Etten RA. Requirement for CD44 in homing and engraftment of BCR-ABL-expressing leukemic stem cells. Nat Med. 2006;12:1175-1180.
91. Giuliani N, Colla S, Morandi F, et al. Myeloma cells block RUNX2/CBFA1 activity in human bone marrow osteoblast progenitors and inhibit osteoblast formation and differentiation. Blood. 2005;106:2472-2483.
92. Kalinkovich A, Tavor S, Avigdor A, et al. Functional CXCR4-expressing microparticles and SDF-1 correlate with circulating acute myelogenous leukemia cells. Cancer Res. 2006;66:11013-11020.
93. Burger M, Hartmann T, Krome M, et al. Small peptide inhibitors of the CXCR4 chemokine receptor (CD184) antagonize the activation, migration, and antiapoptotic responses of CXCL12 in chronic lymphocytic leukemia B cells. Blood. 2005;106:1824-1830.
94. Qian F, Vaux DL, Weissman IL. Expression of the integrin [alpha]4[beta]1 on melanoma cells can inhibit the invasive stage of metastasis formation. Cell. 1994;77:335-347.
95. Kren A, Baeriswyl V, Lehembre F, et al. Increased tumor cell dissemination and cellular senescence in the absence of beta(1)-integrin function. Embo J. 2007;26:2832-2842.
96. Jager S, Jahnke A, Wilmes T, et al. Leukemia targeting ligands isolated from phage display peptide libraries. Leukemia. 2007;21:411-420.
97. + channel form a macromolecular signaling complex in acute myeloid leukemia: role in cell migration and clinical outcome. Blood. 2007;110:1238-1250.
98. Burger JA, Kipps TJ. CXCR4: a key receptor in the crosstalk between tumor cells and their micro-environment. Blood. 2006;107:1761-1767.
99. Till KJ, Spiller DG, Harris RJ, Chen H, Zuzel M, Cawley JC. CLL, but not normal, B cells are dependent on autocrine VEGF and alpha4beta1 integrin for chemokine-induced motility on and through endothelium. Blood. 2005;105:4813-4819.
100. Fragoso R, Pereira T, Wu Y, Zhu Z, Cabecadas J, Dias S. VEGFR-1 (FLT-1) activation modulates acute lymphoblastic leukemia localization and survival within the bone marrow, determining the onset of extramedullary disease. Blood. 2006;107:1608-1616.
101. Kaplan RN, Riba RD, Zacharoulis S, et al. VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature. 2005;438:820-827.
102. Hiratsuka S, Watanabe A, Aburatani H, Maru Y. Tumour-mediated upregulation of chemoattractants and recruitment of myeloid cells predetermines lung metastasis. Nat Cell Biol. 2006;8:1369-1375.
103. Walkley CR, Olsen GH, Dworkin S, et al. A micro-environment-induced myeloproliferative syndrome caused by retinoic acid receptor [gamma] deficiency. Cell. 2007;129:1097-1110.